USA Medical Device Registration Cost 2026: U.S. Agent Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

How Much Does It Cost to Register a Medical Device in the United States in 2026?

For a single foreign-manufactured device entering the U.S. in 2026, the post-clearance representation and registration maintenance budget runs roughly USD 14,500–22,000 in Year 1 and USD 12,500–18,000 per year thereafter, excluding the 510(k)/De Novo/PMA submission itself. The largest fixed line is the FDA annual establishment registration fee — $11,423 in FY 2026, up 23.1% year-over-year — paid directly to FDA and identical regardless of vendor.

The variable line — and what this guide is about — is the U.S. Agent and Official Correspondent service fee every foreign manufacturer pays year after year for the U.S. legal entity that receives FDA correspondence, coordinates inspections, processes establishment registration in FURLS/DRLM, and maintains device listings under 21 CFR Part 807. That recurring fee runs $1,000–$5,000+/year depending on pricing model. Over a 3-year hold, the spread between cheapest and most expensive can exceed 5x for the same scope of work.

Scope note. This guide is about post-clearance maintenance services — U.S. Agent designation, Official Correspondent role, FDA establishment registration, device listing in FURLS, GUDID/UDI maintenance, and routine FDA correspondence. It is not about the cost of a 510(k), De Novo, or PMA submission itself. The 510(k) consulting fee, premarket testing budget, and FDA review fee are separate workstreams and live in How Much Does a 510(k) Cost? Complete 2026 Budget Breakdown. This article is about the recurring vendor relationship that runs after you clear FDA.

U.S. Representation Pricing Model	Year 1 Service Fee	Year 2+ Annual Service Fee	3-Year Service Fee Total
Hourly billing (boutique consulting firms)	$4,500–$9,000	$2,500–$6,000	$9,500–$21,000
Registration fee + annual (mid-market RA firms)	$2,500–$5,000 setup + $2,000–$4,000 yr	$2,000–$4,000	$6,500–$13,000
Flat all-inclusive annual fee (Pure Global)	$1,000	$1,000	$3,000

FDA government fees ($11,423/year establishment registration in FY 2026, plus 510(k)/De Novo/PMA review fees if you submit) are passed through at cost in every model. The number in your service-vendor invoice is the only place you have negotiating leverage. This guide is about how to use it.

Skip to Your Scenario

• First-time foreign manufacturer entering the U.S.: Read Scenario A — the U.S. Agent/Official Correspondent line is recurring for the life of your registration.
• Multi-establishment manufacturer (e.g., contract manufacturer + specification developer): Read Scenario C — each establishment requires its own registration and its own $11,423 fee.
• You already have a U.S. Agent and want to switch: Skip to the U.S. Agent Switching Playbook.
• Issuing an RFP this week: Skip to the RFP Template and 8 questions to ask.
• Want to validate the numbers: Read the Named Provider RFP Comparison.
• Budgeting around QMSR/eSTAR/PCCP churn: Read What 2026 FDA Regulatory Churn Costs.

Why U.S. Agent and Official Correspondent Pricing Is Where U.S. Budgets Quietly Bleed

Every foreign establishment that manufactures, prepares, propagates, compounds, or processes a medical device imported into the United States must designate a U.S. Agent under 21 CFR 807.40 and identify an Official Correspondent for FDA communications. These two designations are typically filled by the same vendor, and together they form the single recurring line every foreign manufacturer pays for as long as the device is on the U.S. market.

What the U.S. Agent and Official Correspondent actually do (and what they don't):

Function	In / Out of Scope
Receive FDA correspondence on behalf of foreign establishment	In
Assist FDA in scheduling and coordinating inspections	In
File annual establishment registration in FURLS/DRLM	In (for hire)
File and maintain device listings in FURLS	In (for hire)
Pay the $11,423 registration fee on the manufacturer's behalf	In — passed through at cost
Process GUDID/UDI submissions	Sometimes (per vendor scope)
Prepare a 510(k), De Novo, or PMA submission	Out — separate consulting workstream
Conduct premarket testing or clinical studies	Out
Perform 21 CFR Part 820 / QMSR internal audits	Out (unless contracted separately)
Act on behalf of the establishment in regulatory decisions	Out — agent role is communication, not authority

The U.S. Agent role is, by FDA's own definition, narrow. It is communication, registration, and correspondence — not premarket strategy, not dossier preparation. That narrowness is why this line is mispriced: most foreign manufacturers are quoted U.S. Agent fees by the same firm that prepared their 510(k), buried as a "$5,000/year" line in the engagement letter. Once cleared, that fee continues to bill for what is, mechanically, a mailbox plus an annual FURLS login.

This is one of the few line items in FDA compliance where the buyer has clear negotiating leverage: scope is statutorily defined (21 CFR Part 807), no FDA credential is required, switching is a one-day FURLS update, and FDA fees are public. The catch: most U.S. Agent pricing is not published, and most foreign manufacturers signed up with whichever firm prepared their 510(k) without ever issuing a separate RFP for the recurring agent role.

The Three U.S. Agent and Official Correspondent Pricing Models, Decoded

Model 1: Hourly billing ("charge by hour")

The default model for boutique RA consulting firms in the U.S. and the historical industry standard for one-off agent work. Scope is captured in a Statement of Work; everything outside scope (e.g., responding to an FDA Form 483 inquiry, processing a sudden device listing change, coordinating an unannounced inspection) is billed at hourly rates that typically run $150–$450/hour depending on tier:

Consultant Tier	U.S. Hourly Rate (2026)	Typical Work
Tier 1 — senior regulatory strategist / former FDA reviewer	$375–$450/hr	FDA escalations, warning letter response, pre-submission strategy
Tier 2 — regulatory specialist	$275–$325/hr	Listing maintenance, FURLS updates, GUDID submissions, correspondence drafting
Tier 3 — associate / RA coordinator	$150–$200/hr	Routine establishment registration, account administration, document filing

(Source: MedDeviceGuide Medical Device Regulatory Consulting Hourly Rates by Region.)

Why buyers choose hourly: flexibility, perceived control, ability to use the agent only when activity occurs.

Why hourly is bad for buyers in practice:

• No incentive to be efficient. Every hour spent — including reading routine FDA emails — is revenue.
• Surprise invoices around the renewal window. The Oct 1–Dec 31 establishment registration renewal generates 4–8 hours; at Tier 2 rates, $1,100–$2,600 just for renewal, separate from the $11,423 government fee.
• Listing changes nickel-and-dime. Adding a listing after a 510(k) clearance is 2–4 hours; UDI/GUDID updates for label changes 2–6 hours. Each triggers an invoice.
• Disincentive to communicate. Every email, every status update, every clarification call is billable — so manufacturers ask fewer questions and miss FDA deadlines.

A typical hourly U.S. Agent engagement for a single foreign establishment runs $4,500–$9,000 in Year 1 and $2,500–$6,000/year thereafter.

Model 2: Registration fee + lower annual maintenance

The dominant model for mid-to-large RA service firms today, especially the ones that bundle U.S. Agent services into a 510(k) consulting engagement. Buyer pays a one-time setup fee plus a smaller recurring annual fee. Scope is bundled but each "extra" is itemized.

Typical structure:

Component	Single-Establishment Foreign Manufacturer
One-time setup / FURLS account onboarding	$1,500–$3,000
First-year U.S. Agent + Official Correspondent retainer	$2,000–$4,000
Annual U.S. Agent + Official Correspondent retainer (Year 2+)	$2,000–$4,000
Per-listing addition (each new device after first)	$300–$1,500
GUDID / UDI submission (per DI)	$250–$1,000
eSTAR / FDA portal liaison for premarket queries	usually billed hourly above retainer
Form 483 / inspection observation triage	usually billed hourly above retainer
FURLS account migration (when switching agents)	$500–$2,500 transfer fee

The trap: the marketing message is "low annual fee," but Year 1 actual spend is usually $3,500–$7,000 because setup fee + retainer + listing fees + UDI submissions all fire in the same 60-day window after clearance.

Where this model fails buyers:

• Per-listing fees are unbounded. Manufacturers with 5+ listings pay $1,500–$7,500/year just in maintenance.
• GUDID is billed by the DI. 30 SKUs × $500/DI = $15,000 to populate GUDID once, and again on each attribute change.
• Inspection coordination falls outside retainer. When FDA's foreign inspection program contacts your agent, the work is usually billed hourly above retainer.
• Transfer/exit fees are punitive. $1,500–$3,000 to move a FURLS account to a new agent, plus 60–90 days notice.

Model 3: Flat all-inclusive annual fee

A pricing model where the agent charges a single annual fee that includes the U.S. Agent designation, Official Correspondent role, establishment registration in FURLS, device listing maintenance, routine FDA correspondence, and standard inspection coordination. The same number every year, year 1 to year N.

This model has two structural advantages over hourly and reg+annual:

1. The fee curve is flat. Year 1 cost equals Year 2 cost equals Year 3 cost. Setup work is amortized into the recurring fee.
2. The agent's incentives align with yours. Once you sign, every additional hour the agent spends is pure cost to them. They are economically motivated to file cleanly and avoid back-and-forth with FDA.

The catch: flat-fee agents typically scope the engagement narrowly — i.e., the flat fee covers the agent + correspondent + registration role but explicitly excludes dossier preparation (510(k), De Novo, PMA), premarket testing oversight, QMSR consulting, warning letter response, and clinical study coordination. Those workstreams are separately quoted.

This model is also rare. As of April 2026, Pure Global is among the only major U.S. Agent / Official Correspondent service providers that publishes a complete flat-fee schedule on its website (pureglobal.com/services/pricing), which makes it the only public reference point for buyers benchmarking the recurring agent line.

Why this guide uses Pure Global as the worked example

We use Pure Global's published U.S. Agent rates throughout this article because they are the only flat-fee U.S. Agent rates in the public domain — anyone can verify them at pureglobal.com/services/pricing. This is not an endorsement and not every reader will choose Pure Global. The published rates simply let us do an apples-to-apples cash flow comparison that would otherwise require RFPs to multiple firms operating under NDA. Industry ranges shown for hourly and front-loaded models are based on typical RFP responses, published consulting hourly rate benchmarks, and procurement data collected by MedDeviceGuide.

Recommended Reading

FDA Export Certificates for Medical Devices: CFS, CFG, COE Complete Guide

Regulatory Reimbursement & Market Access2026-04-17 · 14 min read

Pure Global U.S. Agent and Official Correspondent Pricing (Published, April 2026)

Annual Service Fee

Service	Classification	Annual Flat Fee (USD)
U.S. Agent + Official Correspondent + Establishment Registration support	All Classes	$1,000 / year

Included in the $1,000 annual fee — per Pure Global's published price list and pricing page:

• U.S. Agent designation under 21 CFR 807.40 — U.S. mailing address, FDA point of contact
• Official Correspondent role — designated recipient of FDA communications on registration and listing
• Support for annual FDA establishment registration in FURLS/DRLM
• Guidance on FDA annual user fee processing (Pay.gov / DUNS / DFUF transactions for the $11,423 fee)

Inherent to the U.S. Agent statutory role under 21 CFR 807.40 (included by definition, not separately billable):

• Receiving and forwarding routine FDA correspondence to the foreign establishment
• Assisting FDA in scheduling inspections of the foreign establishment
• Responding to FDA's questions about products imported or offered for import

Confirm scope before signing — these activities are not itemized on Pure Global's published price list, so verify in writing whether they sit inside the $1,000 annual fee or are quoted separately:

• Device listing filings under 21 CFR 807.21 (initial listing, modifications, inactivations)
• GUDID/UDI Direct Marking submissions under 21 CFR 830
• Labeling-change-driven listing updates
• Bulk GUDID DI population for large SKU portfolios — typically priced as a one-time project, not in any agent retainer
• Routine vigilance/MDR triage under 21 CFR 803 (forwarding vs analysis)

Explicitly excluded — separately quoted on Pure Global's published consulting menu (see next section for line-item rates): 510(k) / De Novo / PMA preparation, pre-submission (Q-Sub) support, regulatory pathway determination, premarket testing oversight, clinical investigation management, QMSR audits, warning letter / Form 483 response, training.

Government fees passed through at cost (no markup): $11,423 establishment fee (FY 2026), $26,067 / $6,517 510(k) review fee, $173,782 / $43,446 De Novo, $579,272 / $144,818 PMA.

Optional Consulting Services (Separate Engagement)

For manufacturers who want to bundle premarket consulting with U.S. Agent services through one vendor, Pure Global also publishes its consulting rates. Note: these are not part of the $1,000 U.S. Agent fee — they are separate engagements quoted per project.

Service	Classification	Fee (USD)	Frequency
Regulatory Pathway determination	All Classes	$5,000	Per project
Pre-Submission (Q-Sub) support	All Classes	$10,000–$15,000	Per project
510(k) compilation and submission	Class II (typical)	$15,000–$20,000	Per submission
510(k) post-submission support	All Classes	Quoted on consultation	Per submission
De Novo compilation and submission	Class II (typical)	Quoted on consultation	Per submission
Training	All Classes	$250 / hour	Per hour
RAQA ad-hoc support	All Classes	$250 / hour	As needed

(Source: pureglobal.com/services/pricing, captured April 2026. Price list version 1.1, last updated 2026-01-12.)

The published $1,000/year U.S. Agent fee is competitive at the low end of the market. Web-published competitor rates for U.S. Agent-only services typically run $1,500–$5,000/year, with the higher tier reflecting bundled inspection-coordination services. The Pure Global flat fee is meaningfully below the median for the same statutory scope.

3-Year Cash Flow: Side-by-Side Comparison

The pricing model only matters because of cash timing and scope creep. The following scenarios show the same scope of work — U.S. Agent + Official Correspondent + establishment registration + routine device listing maintenance for a foreign manufacturer, FDA government fees passed through at cost — under each of the three models.

Scope assumption. The Pure Global flat-fee column in these scenarios assumes that routine device listing maintenance (additions, modifications, inactivations) and GUDID submissions for normal-volume portfolios are inside the $1,000/year fee, consistent with typical Official Correspondent practice. Pure Global's published price list itemizes only U.S. Agent, Official Correspondent, establishment registration support, and user-fee processing guidance — listing and GUDID are not separately itemized. Always confirm in writing before signing. Bulk GUDID DI population for large SKU portfolios is typically scoped as a separate one-time project under any vendor.

Scenario A: Single Class II 510(k)-Cleared Device, 3-Year Total

A foreign manufacturer with a newly cleared Class II device, maintaining U.S. Agent services for the recurring obligation.

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 — initial FURLS setup + first registration	$3,000 (15 hrs blended × $200)	$2,500 setup	$1,000
Year 1 — initial device listing + GUDID/UDI account	$1,500 (8 hrs T2 × $185)	$1,000 (1 listing + GUDID base)	included
Year 1 — agent retainer (12 months)	$2,000 (10 hrs T2 ad-hoc)	$2,500 retainer	included
Year 1 service fee total (excludes $11,423 FDA fee)	$6,500	$6,000	$1,000
Year 2 — agent retainer + 1 listing change	$3,500	$3,000 ($2,500 retainer + $500 listing)	$1,000
Year 3 — agent retainer + 1 listing change + 1 GUDID update	$4,000	$3,500	$1,000
3-Year service-fee total	$14,000	$12,500	$3,000
Year 1 share of 3-year service spend	46%	48%	33%
FDA establishment registration fee (3 × $11,423)	$34,269	$34,269	$34,269
3-Year all-in total (service + FDA fee)	$48,269	$46,769	$37,269

The Year 1 service fee burden under flat fee is $1,000 vs $6,500 under hourly — for the same statutory output. Over three years the flat-fee buyer saves $11,000 on the service line alone. Note that the FDA establishment fee ($11,423/year × 3 = $34,269) dominates the all-in total in every model — but it is the same in every model. The only place the buyer saves real money is on the service fee.

Scenario B: Single Class II Device with Active Listing Maintenance

A device on the U.S. market for several years, accumulating 2–3 listing changes per year (relabeling, GUDID updates, site moves).

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 — agent retainer + 3 listing changes + 2 GUDID updates	$7,500 (35 hrs blended)	$5,500 ($2,500 retainer + $1,500 listing + $1,500 GUDID)	$1,000
Year 2 — agent retainer + 2 listing changes + 1 GUDID update	$5,000	$4,000	$1,000
Year 3 — agent retainer + 3 listing changes + 1 GUDID update	$5,500	$4,500	$1,000
3-Year service-fee total	$18,000	$14,000	$3,000
Year 1 share	42%	39%	33%

For a portfolio that genuinely uses the agent for what they exist to do — listing maintenance, GUDID upkeep, FDA correspondence — the flat-fee model is 6.0x cheaper than hourly and 4.7x cheaper than reg+annual over three years. The hourly meter is the most expensive option whenever the manufacturer is commercially active enough to actually generate listing changes.

Scenario C: 3-Establishment, Multi-Listing Portfolio

Three registered establishments (contract sterilizer, specification developer, foreign manufacturing facility), 8 device listings total. Each establishment pays the $11,423 FDA fee separately and requires its own U.S. Agent designation (though one agent can serve all three).

Cost Bucket	Hourly Billing	Registration + Annual	Flat Fee (Pure Global)
Year 1 — service fees, 3 establishments × 8 listings	$18,000–$25,000	$12,000–$18,000	3 × $1,000 = $3,000
Year 2	$9,000–$15,000	$7,500–$12,000	$3,000
Year 3	$9,000–$15,000	$7,500–$12,000	$3,000
3-Year service-fee total	$36,000–$55,000	$27,000–$42,000	$9,000
FDA fees (3 establishments × 3 years × $11,423)	$102,807	$102,807	$102,807
3-Year all-in	$138,807–$157,807	$129,807–$144,807	$111,807

For multi-establishment portfolios the spread compounds quickly. The flat-fee model is 4.0x to 6.1x cheaper than hourly on the service line. And again, FDA's establishment registration fee is the unavoidable elephant — the only variable line is the agent fee.

What "All-Inclusive" Actually Means: U.S. Agent Scope Checklist

When U.S. Agent proposals all claim to "include everything," the differences are in the fine print. Use this checklist to compare proposals line by line.

Service Item	Hourly (typical)	Reg + Annual (typical)	Flat Fee — Pure Global
U.S. Agent designation under 21 CFR 807.40	hourly	included	included (published)
Official Correspondent role	hourly	included	included (published)
Annual FURLS/DRLM establishment registration filing	$400–$1,200	included	included (published)
Pay.gov user fee processing guidance	included or $200–$500	included	included (published)
FDA correspondence forwarding (routine)	hourly per email	included	inherent to statutory role
FDA inspection scheduling coordination	hourly	hourly above retainer	inherent to statutory role
Initial device listing (1st device)	$400–$1,200	included or $300–$1,500	confirm with provider
Additional device listings (each)	$400–$800 each	$300–$1,500 each	confirm with provider
Device listing modifications	hourly	$300–$1,500 each	confirm with provider
Device listing inactivation	hourly	$200–$500 each	confirm with provider
GUDID account setup	hourly	$1,000–$3,000 setup	confirm with provider
GUDID per-DI submission (initial)	hourly	$250–$1,000 each	confirm with provider — bulk portfolios usually priced as project
GUDID attribute updates (post-clearance)	hourly	$250–$1,000 each	confirm with provider
MDR / vigilance triage (forwarding vs analysis)	hourly	hourly	forwarding inherent to role; analysis = $250/hr RAQA
510(k) / De Novo / PMA preparation	not in agent scope	not in agent scope	excluded — separate consulting menu ($15,000–$20,000 510(k); De Novo TBD)
Pre-submission (Q-Sub) preparation	not in agent scope	not in agent scope	excluded — $10,000–$15,000 per project
Regulatory pathway determination	not in agent scope	not in agent scope	excluded — $5,000 per project
Premarket testing oversight	not in agent scope	not in agent scope	excluded
QMSR / 21 CFR Part 820 audits	not in agent scope	not in agent scope	excluded
Warning letter / Form 483 response strategy	hourly	hourly	excluded — $250/hour RAQA ad-hoc
Training	hourly	hourly	excluded — $250/hour
FURLS account transfer / exit	hourly	$500–$2,500 transfer fee	no separate exit fee
Annual fee escalation clause	uncapped	typically CPI-linked	published rate, no automatic escalator
FDA government fees ($11,423 / $26,067 / etc.)	passed through at cost	passed through at cost	passed through at cost (no markup)

How to read "confirm with provider" rows: Pure Global's public price list itemizes the four roles above (U.S. Agent, Official Correspondent, establishment registration support, user fee guidance). Most U.S. Agent firms perform device listing and routine GUDID submissions inside the same FURLS account they use for establishment registration, so it is typical (but not contractually published) for these to be inside the flat fee. Always get the inclusion of listing maintenance and GUDID maintenance written into the engagement letter explicitly — the RFP template below forces this disclosure.

The scope items that quietly drive Year-2-and-beyond cost overruns under hourly and reg-plus-annual models are: per-listing fees, GUDID per-DI fees, and FDA correspondence handling time. Together they generally account for 50–80% of post-Year-1 service spend. Whether they are inside or outside the flat fee is the single biggest line in any side-by-side comparison.

Recommended Reading

Brazil Medical Device Registration Cost 2026: BRH Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison

ANVISA Reimbursement & Market Access2026-04-24 · 34 min read

What 2026 FDA Regulatory Churn Costs Under Each Pricing Model

The U.S. regulatory environment between 2022 and 2026 has been more active than at any time since the Safe Medical Devices Act of 1990. Each rule change forces existing registrations to file modifications, regenerate UDI/GUDID submissions, update labeling, or refresh their listings. Under hourly billing or reg-plus-annual, every one of those filings is a billable event. Under flat fee, they are not. This is the line that competitors do not bring up during the sales call.

Modification and Maintenance Volume from 2022–2026 FDA Rules

Regulation / Initiative	Effective	Listing Impact	Touches per Device
eSTAR mandate for 510(k)	October 2023	All 510(k) modifications via eSTAR	1 per modification
eSTAR mandate for De Novo	January 2024	De Novo migration to eSTAR	1 per submission
GUDID system updates and portal migrations	2024–2025	Account refresh, attribute re-validation	1–3 GUDID updates
Cybersecurity premarket guidance	Sept 2023	SBOM submissions, cybersecurity labeling	1–2
PCCP final guidance (AI/ML)	August 2024	PCCP submissions per AI/ML device	1–2
QMSR final rule	Feb 2, 2026	Quality manual + DHF + label cascade	1–3 refreshes
MDUFA V annual fee adjustments	Annually	Establishment fee increases (+23% FY26)	1 annual cycle
21 CFR 803 MDR e-submission updates	Phased 2024–2026	E-MDR account validation	1–2 per cycle
GUDID per-DI submissions for new SKUs	Ongoing	1 GUDID record per new SKU	1–N per SKU

Aggregated, a typical Class II device has triggered 5–10 cumulative listing/UDI touches since 2022. AI/ML-enabled and connected devices subject to cybersecurity guidance trigger 8–15 touches.

What That Maintenance Volume Costs You

Pricing Model	Per-Touch Cost	4-Year Cost (Class II, 5 touches)	4-Year Cost (AI/ML or connected device, 12 touches)
Hourly billing (3–6 hrs × $235 blended)	$700–$1,400	$3,500–$7,000	$8,400–$16,800
Reg fee + annual ($300–$1,500 each)	$300–$1,500	$1,500–$7,500	$3,600–$18,000
Pure Global flat fee	included	$0 incremental	$0 incremental

Under hourly or reg-plus-annual, regulatory churn becomes a hidden tax that scales with how active FDA is — not with how active you are. FDA's CDRH is currently rolling out the largest set of QMS, premarket, and post-market changes in 25 years. That is exactly the wrong environment in which to sign a 3-year hourly U.S. Agent contract.

What FDA Has Queued for 2026–2028

Pipeline finalized or in active rulemaking, each of which will trigger fresh listing touches:

• QMSR effective date (February 2, 2026) — every manufacturer must align quality manual to the ISO 13485-incorporated framework. Not a listing event itself, but generates downstream labeling and DHF updates that touch listings.
• eSTAR universal adoption — all 510(k)s and De Novos eSTAR-only; PMAs may follow.
• PCCP submissions for AI/ML devices — 1–2 PCCP filings per AI/ML device through 2028.
• Cybersecurity post-market guidance — additional labeling and SBOM update cycles through 2027.
• GUDID database modernization — platform migration 2026–2028 will require labeler portal re-authentication for every registered manufacturer.
• MDUFA V annual fee adjustments — establishment fee almost certainly keeps climbing. FY 2026 was +23%.

A reasonable 2026–2028 forecast for a connected Class II device is 3–5 additional listing/UDI/PCCP touches — $2,500–$8,000 per device on the agent line under hourly. Under flat fee, $0. For a portfolio of 8 listings across 3 establishments, the spread over 2026–2028 is $15,000–$50,000 in net U.S. P&L impact.

When Flat Fee Wins, and When It Does Not

Flat fee is not universally the best choice. The decision framework:

Flat fee usually wins when:

• You expect to keep the device on the U.S. market for ≥3 years (which is virtually every cleared device).
• You have ≥1 active listing that generates ongoing FURLS/GUDID maintenance (almost every commercially active foreign manufacturer).
• You want predictable annual operating expense — particularly important for finance teams modeling steady-state U.S. costs.
• You are pre-revenue or capital-constrained in Year 1.
• You do not want to micromanage hourly billing or audit consultant invoices.
• You have AI/ML or cybersecurity-relevant devices that will trigger PCCP and SBOM filings.

Hourly billing might still win when:

• You are doing a one-time discovery exercise (e.g., a regulatory feasibility assessment) and do not yet have a 510(k) cleared.
• Your device has been on the U.S. market for years and has zero listing changes — pure mailbox-only role with no GUDID activity.
• You need ad-hoc strategic counsel (e.g., responding to a 483 observation) outside an existing agent relationship.

Registration-fee-plus-annual is rarely the optimal choice on TCO grounds. It typically lands between hourly and flat fee on cost while preserving the cash flow problem of Year 1 front-loading and the per-listing nickel-and-dime problem of years 2+.

Government Fees: A Quick Reference

U.S. Agent service fees are excluded from FDA government fees in every pricing model — the agent passes them through at cost. For completeness, the official FY 2026 government fees (October 1, 2025 – September 30, 2026) are:

FDA Fee	FY 2026 Standard	FY 2026 Small Business
Annual establishment registration	$11,423	$11,423 (no reduction)
510(k) review fee	$26,067	$6,517
513(g) request for information	$7,820	$3,910
De Novo classification request	$173,782	$43,446
PMA / PDP / PMR / BLA	$579,272	$144,818
Panel-track supplement	$463,418	$115,855
180-day supplement	$86,891	$21,723
Real-time supplement	$40,549	$10,137
30-day notice	$9,268	$4,634
Annual periodic reporting (Class III)	$20,275	$5,069

For a complete breakdown of FDA user fees, including the FY 2026 establishment registration waiver for micro-businesses ($1M revenue + financial hardship), see FDA User Fees 2026: Complete MDUFA Fee Schedule. For the registration and listing process itself, see FDA Establishment Registration & Device Listing: Complete Compliance Guide.

Recommended Reading

Medical Device Registration Cost by Country: 2026 Global Comparison

510(k) CE Marking2026-04-14 · 26 min read

8 Questions to Ask Any U.S. Agent Before You Sign

This checklist works regardless of which agent you are evaluating. Demand explicit, written answers before signing — not verbal assurances during the sales call.

1. Is the fee fixed for the contract term, or subject to annual escalation? If escalation: capped at what (CPI? uncapped?). Many U.S. agents auto-escalate at 5–8% per year unless capped.
2. How many device listings are included per year? "Unlimited" should be in writing. "Reasonable use" is a red flag.
3. How many listing modifications and GUDID updates are included per year? What counts as a modification (label change? SKU addition? manufacturing site change? UDI-DI attribute update)?
4. What is the per-hour rate for out-of-scope work? Some firms advertise low base fees and charge $400+/hour for anything outside scope.
5. Who handles FDA inspection coordination? When FDA's foreign inspection program contacts your agent, is the coordination work inside the retainer or billed hourly above it?
6. What are the termination terms? What is the notice period? Is there a transfer fee at exit? What is the FURLS account hand-off process?
7. Does the agent assert any right to delay FURLS account transfer during a billing dispute? Some firms hold the FURLS account hostage. Get the transfer-out commitment in writing before signing.
8. Will the agent provide written confirmation of the U.S. Agent designation immediately upon signing, suitable for filing with FDA? You need this within 7 days of paying the retainer.

If a U.S. Agent service provider refuses to answer any of these in writing, that is the answer to the question.

U.S. Agent Switching Playbook: How to Leave Without Getting Trapped

The single most expensive mistake in U.S. Agent selection is signing a contract you cannot exit affordably. Many foreign manufacturers discover, two years in, that their agent is mediocre — slow on FDA correspondence, sloppy on listings, $5,000/year for what amounts to a forwarded inbox — but switching feels harder than staying. This section is the operational playbook.

The U.S. Agent Change Procedure

Unlike Brazil's Transferência de Titularidade or the EU's Authorized Representative transfer, changing a U.S. Agent in FURLS is a single-step operation that does not require FDA pre-approval. Total realistic timeline: 3–14 days — far faster than EU AR or Brazil BRH transfers.

Step	Duration	Notes
1. Sign new agent agreement	1–7 days	New agent provides U.S. address
2. Log into FURLS/DRLM	1 day	Credentials tied to manufacturer, not outgoing agent
3. Update U.S. Agent designation in FURLS	1 day	FDA accepts immediately upon submission
4. New agent receives FDA confirmation email	1–14 days	Sent to both manufacturer and new agent
5. Outgoing agent's role formally ends	Immediate	No outgoing-agent signature required

The bottleneck is not FDA — it is the FURLS account credentials. If your outgoing agent set up the FURLS account in their own name, you may need to recover access or create a new FURLS account and re-register from scratch. This is the trap to avoid.

Contract Termination Clauses: How They Actually Compare

The termination clause buried in your U.S. Agent contract is often more economically consequential than the headline annual fee. Common terms in the market:

Termination Term	Typical Industry Practice	Buyer-Friendly Term
Notice period required	60–90 days	30 days or none
Payoff of remaining contract value on early exit	Sometimes 100% remaining year	Pro-rated to month
FURLS account ownership	Sometimes asserted by agent	Should always be in manufacturer's name
Separate "transfer fee" charged at exit	$500–$2,500 typical	None
Right to retain unforwarded FDA correspondence during a billing dispute	Sometimes asserted in fine print	Explicitly waived

If you sign a typical industry U.S. Agent contract today that requires 90 days notice plus a $2,000 transfer fee on a $4,000/year deal, the effective cost of switching mid-contract is $1,000 (notice fees) + $2,000 (transfer fee) = $3,000 — comparable to 3 years of flat-fee under Pure Global's published rate.

The FURLS-Account-in-Agent's-Name Trap

The most common trap: letting the U.S. Agent create the FURLS account in the agent's name rather than the manufacturer's name. If the agent owns the FURLS account, switching may require creating a brand-new account, re-registering the establishment, and re-listing every device — 4–12 hours and a registration gap risk. You may also re-pay the $11,423 establishment fee if a fiscal year boundary falls during the switch (FDA does not pro-rate or refund).

The right structure: FURLS account in the manufacturer's name, agent granted sub-account access. Switching becomes a 1-day update, not a re-registration project.

Distributor-as-Agent Lock-In

A second trap: letting your U.S. distributor double as your U.S. Agent. Identical to the Brazil distributor-as-BRH problem — if the commercial relationship sours, the distributor controls your agent designation, FDA correspondence, and FURLS account. Always retain an independent U.S. Agent, separate from your importer of record.

Clean Switching: 7-Step Sequencing

1. Confirm the FURLS account is in your name before signing the new agent agreement. Recover ownership first if not.
2. Sign the new agent agreement with effective date of FDA confirmation, not contract date.
3. Time the switch outside the Oct 1 – Dec 31 renewal window to avoid colliding with annual fee payment.
4. Update the U.S. Agent designation in FURLS the same day you sign.
5. Send a written termination notice to the outgoing agent citing the notice period clause.
6. Confirm the new agent receives the FDA confirmation email within 14 days.
7. Update the U.S. Agent contact in your QMS, regulatory file, and FDA submission cover letters — stale agent info in a 510(k) cover letter is an avoidable Refuse-to-Accept trigger.

A well-executed U.S. Agent switch costs $0–$1,500 and 7–14 days. A poor one can lapse your registration and expose you to import detention.

Named Provider RFP Comparison: Pure Global vs Typical Competitor Quotes

We modeled the same scope — U.S. Agent + Official Correspondent + establishment registration + maintenance for a single foreign manufacturer with one Class II 510(k)-cleared device, 3-year hold — under three pricing structures: Pure Global (rates verified on its public pricing page), and two composite industry quotes (hourly and registration-fee-plus-annual) built from typical RFP responses. The comparison uses the midpoint of each composite range; Pure Global uses the published rate. Competitor firms are not named individually because they do not publish prices.

Scope baseline: 1 foreign establishment, 1 Class II 510(k)-cleared device, 1 GUDID record, 2 listing modifications per year, 3-year hold. FDA government fees passed through at cost in every model.

Line Item	Pure Global (Flat Fee)	Composite Hourly Quote	Composite Reg+Annual Quote
Year 1 — agent retainer (12 months)	$1,000 (annual fee)	$2,500 (12 hrs T2 × $200 base)	$2,500 retainer
Year 1 — FURLS account setup	included	$1,500 (8 hrs T2/T3 blended)	$1,500–$2,500 setup
Year 1 — 1 device listing + GUDID setup	included	$1,800 (10 hrs T2)	$1,000–$2,500
Year 1 — 2 listing modifications	included	$940 (4 hrs T2)	$600–$2,500
Year 1 service total	$1,000	$6,740	$5,600–$10,000
Year 2 — agent retainer	$1,000	$2,500	$2,500
Year 2 — 2 listing modifications + GUDID update	included	$1,400 (6 hrs T2)	$800–$3,000
Year 3 — agent retainer	$1,000	$2,500	$2,500
Year 3 — 2 listing modifications + GUDID update	included	$1,400	$800–$3,000
3-Year service-fee total	$3,000	$14,540	$12,200–$21,000
FDA establishment fee (3 × $11,423) — passed through	$34,269	$34,269	$34,269
3-Year all-in (service + FDA fee)	$37,269	$48,809	$46,469–$55,269

(Pure Global rates verified at pureglobal.com/services/pricing. Composite ranges drawn from typical U.S. Agent RFP responses observed by MedDeviceGuide; individual firm numbers vary.)

Key Takeaways from the Comparison

• Pure Global at the published rate is 4.8x cheaper than the composite hourly quote on the service line over 3 years, and 4.1x to 7.0x cheaper than the composite reg+annual quote.
• The cost gap widens further in Years 2 and 3 if the device generates above-average listing activity — which, given 2026 FDA churn (QMSR rollout, GUDID modernization, PCCP filings, cybersecurity guidance), is the realistic case for almost every commercially active device.
• The reg-plus-annual model has the widest bracket because providers vary enormously on whether per-listing fees and GUDID updates are inside the annual retainer or billed separately. Read every "included" claim line by line.
• The flat-fee model is insulated from invoice variance. The only variable you control is whether you have one establishment or several — everything else is a fixed cost.

Why Composite Instead of Named Competitors

No other major U.S. Agent provider publishes prices — public pages consistently say "starting at $1,500/year" or "contact us for a quote" rather than full schedules. Naming Firm X with a specific number invites disputes we cannot resolve without violating NDAs. The point of this analysis is the structural difference between pricing models, not which specific competitor is best. To get firm-specific pricing, issue your own RFP.

Recommended Reading

Clinical Equivalence Assessment Under EU MDR: Technical, Biological, and Clinical Equivalence

Clinical Evidence EU MDR / IVDR2026-04-24 · 12 min read

U.S. Agent RFP Template Copy and Paste

Most U.S. Agent RFPs come back in three different formats with three different scope inclusion lists, making side-by-side comparison nearly impossible. Use the template below to force every responding firm into the same structure.

---

Subject: Request for Proposal — U.S. Agent and Official Correspondent Services for [Manufacturer Name]

Dear [Provider],

[Manufacturer Name] is a [country]-based medical device manufacturer evaluating U.S. Agent and Official Correspondent service providers for our FDA-registered establishment(s) and device listing portfolio. We are issuing this RFP to [N] firms and request a written proposal by [date].

Establishment Scope

#	Establishment Type	Country	Activities (mfg / spec dev / sterilizer / etc.)	FDA Registration # (if existing)
1	[Manufacturer / Spec Dev / etc.]
2

Device Listing Portfolio

#	Device Name	Product Code	Class	Premarket Clearance #	Anticipated Listing Changes / Year
1
2

Contract Term: We anticipate a [3-year / 5-year] U.S. Agent relationship.

Required Pricing Format

Please provide pricing in the following table for each year of the contract term. Indicate explicitly whether each line item is included in the annual retainer or billed separately, and if separately, on what unit basis.

Service Item	Year 1 Cost	Year 2 Cost	Year 3 Cost	Inclusion (Y/N)	Per-Unit Rate if Separate
U.S. Agent designation under 21 CFR 807.40
Official Correspondent role
FURLS/DRLM annual establishment registration filing
Initial device listing
Additional device listings (each)
Listing modifications — please state limit
Listing inactivations
GUDID account setup
GUDID per-DI submission (initial)
GUDID attribute updates
FDA correspondence routing
FDA inspection coordination
Pay.gov fee processing
Out-of-scope hourly rate (T1 / T2 / T3)
FURLS account transfer fee on exit

Required Disclosures

1. Annual fee escalation clause — fixed, CPI-linked, or uncapped?
2. Notice period required for non-renewal at end of term.
3. Early termination payoff — pro-rated to month, or full remaining year?
4. Whether the FURLS account is created in the manufacturer's name or the agent's name.
5. Any separate "transfer fee" charged at exit — yes/no, amount.
6. FDA government fees — confirm passed through at cost without markup.
7. Whether the agent asserts any right to retain unforwarded FDA correspondence during a billing dispute.
8. Time-to-confirmation: from contract signature, how many days until FDA confirms the U.S. Agent designation?

Evaluation Criteria

We will evaluate proposals on (in order): (1) total 3-year cost at our forecast scope, (2) inclusion completeness — fewer separately-billed line items is better, (3) FURLS account ownership terms, (4) termination clause flexibility, (5) responsiveness during this RFP, (6) FDA correspondence handling track record (please attach 2–3 references).

Please respond by [date] to [contact email].

Best regards,

[Your Name]

[Your Title], [Manufacturer Name]

---

This template forces every provider to price the same scope. The line items where firms diverge most — per-listing fees, GUDID fees, transfer-out fees, and FURLS account ownership — are exactly the items the template makes them disclose. After three to five proposals come back in this format, the right answer is usually obvious within an hour.

Frequently Asked Questions

Is a U.S. Agent the same as an Official Correspondent?

No, but the same entity usually serves both roles. The U.S. Agent is required under 21 CFR 807.40 for foreign establishments and is FDA's primary contact for inspection-scheduling and import-related correspondence. The Official Correspondent is identified during establishment registration as the primary recipient of FDA communications on registration and listing. Most providers fold both roles into one retainer.

Can the manufacturer be its own U.S. Agent?

Only if the foreign manufacturer has a U.S. legal entity with a physical address and a person available during U.S. business hours. Standing up such an entity solely for self-agency typically exceeds the cost of an independent third-party agent for the first decade of U.S. presence.

Can the same U.S. Agent serve multiple foreign establishments?

Yes. There is no FDA-imposed limit. Most large U.S. Agent providers serve hundreds of foreign manufacturers simultaneously.

Does the U.S. Agent prepare the 510(k) submission?

No — the U.S. Agent role is communication, registration, and correspondence. Preparing a 510(k), De Novo, or PMA is a separate consulting engagement. Pure Global offers both, but they are scoped and priced separately. For 510(k) cost details, see How Much Does a 510(k) Cost?.

Does the U.S. Agent pay the $11,423 establishment registration fee on my behalf?

The agent typically processes the payment in DFUF/Pay.gov, but the FDA fee is reimbursed by the manufacturer at cost. If an agent refuses to pass through FDA fees at cost, walk.

What happens if my device gets a Form 483 or warning letter?

The agent receives and forwards the correspondence. Drafting the response is not part of the standard retainer in any pricing model — it is a separate RAQA engagement. Hourly billing runs $375–$450/hr at Tier 1 for warning letter response. Pure Global's flat fee includes routine forwarding; response strategy is billed at $250/hr RAQA.

How does QMSR (effective February 2, 2026) affect U.S. Agent obligations?

QMSR replaces 21 CFR Part 820 with ISO 13485 incorporation. It does not change U.S. Agent obligations directly, but will trigger labeling and DHF updates that cascade into listing modifications and GUDID attribute updates. Under hourly/reg-plus-annual those touches bill; under flat fee they do not. See FDA QMSR Inspection Preparation: CP 7382.850.

How does U.S. Agent cost compare to other major markets?

The U.S. Agent role ($1,000–$5,000/year) sits at the low end. EU Authorized Representative is $3,000–$10,000/year, Brazilian BRH $2,000–$8,000/year, Japan DMAH $15,000–$50,000/year. The U.S. is structurally cheaper because the agent role is narrower (communication, not legal liability). See Medical Device Registration Cost by Country: 2026 Global Comparison.

Do I need a U.S. Agent if I only sell through a U.S. distributor?

Yes, if your foreign establishment is registered. The U.S. Agent obligation is tied to establishment registration, not to the commercial relationship.

Bottom Line

FDA's $11,423/year establishment registration fee is the unavoidable elephant — and it is the same regardless of which agent you pick. The line where U.S. budgets get blown up is the U.S. Agent and Official Correspondent service fee: cash flow shape and whether per-listing nickel-and-diming is inside or outside the retainer. Hourly meters every listing change. Registration-fee-plus-annual adds per-listing fees that compound with regulatory churn. Flat all-inclusive billing flattens cost to ~33% per year and removes the modification meter entirely.

A $1,000/year published flat-fee versus a $4,000–$5,000/year industry midpoint saves roughly $9,000–$12,000 over 3 years — enough to fund the next 510(k) review fee at the small business rate. The 2026 benchmarks change every year. The pricing model questions are timeless. Ask them before you sign.

Related Guides

• FDA Establishment Registration & Device Listing: Complete Compliance Guide
• FDA User Fees 2026: Complete MDUFA Fee Schedule
• How Much Does a 510(k) Cost? Complete 2026 Budget Breakdown
• FDA QMSR Inspection Preparation: CP 7382.850
• FDA eSTAR Electronic Submission Template
• FDA Predetermined Change Control Plan (PCCP) for AI/ML
• Medical Device Registration Cost by Country: 2026 Global Comparison
• Medical Device Regulatory Consulting Hourly Rates by Region